| 标题 |
OA-49 Mezigdomide (MEZI) plus dexamethasone (DEX) and bortezomib (BORT) or carfilzomib (CFZ) in patients (pts) with relapsed/refractory multiple myeloma (RRMM): results from the CC-92480-MM-002 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Clinical Lymphoma Myeloma and Leukemia 作者:Albert Oriol; Irwindeep Sandhu; Marc Raab; Darrell White; Richard LeBlanc; et al 出版日期:2023-09-26 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)